SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-22-000036
Filing Date
2022-01-11
Accepted
2022-01-11 07:00:23
Documents
12
Period of Report
2022-01-11
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 e621207_8k-arct.htm   iXBRL 8-K 23875
  Complete submission text file 0001193805-22-000036.txt   196994

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arct-20220111.xsd EX-101.SCH 3039
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20220111_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20220111_pre.xml EX-101.PRE 22599
6 EXTRACTED XBRL INSTANCE DOCUMENT e621207_8k-arct_htm.xml XML 3628
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 22522722
SIC: 2834 Pharmaceutical Preparations